A Prospective Investigation of Graves' Disease and Selenium: Thyroid Hormones, Auto-Antibodies and Self-Rated Symptoms | Zendy

Jan Calissendorff | Zendy; Emil Mikulski | Zendy; Erik H. Larsen | Zendy; Marika C. Möller | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Prospective Investigation of Graves' Disease and Selenium: Thyroid Hormones, Auto-Antibodies and Self-Rated Symptoms

Author(s) -

Jan Calissendorff,

Emil Mikulski,

Erik H. Larsen,

Marika C. Möller

Publication year - 2015

Publication title -

european thyroid journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.23

H-Index - 10

eISSN - 2235-0802

pISSN - 2235-0640

DOI - 10.1159/000381768

Subject(s) - medicine , endocrinology , hormone , placebo , triiodothyronine , thyroid , thyroid peroxidase , anti thyroid autoantibodies , depression (economics) , anxiety , gastroenterology , antibody , autoantibody , immunology , alternative medicine , macroeconomics , pathology , psychiatry , economics

In Graves' thyrotoxicosis tachycardia, weight loss and mental symptoms are common. Recovery takes time and varies between patients. Treatment with methimazole reduces thyroid hormone levels. According to previous research, this reduction has been faster if selenium (Se) is added.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research